Navigation Links
Decision Resources Group Announces First Medical Device Account Targeting Tool in China
Date:7/31/2014

BURLINGTON, Mass., July 31, 2014 /PRNewswire/ -- Decision Resources Group is launching an extension of its premier medical technology market intelligence product Marketrack to now include ChinaTrack; the new capabilities track the China device landscape in an interactive dashboard providing detailed brand-level share tracking and analytics. ChinaTrack also provides detailed procedure volumes at a hospital level.

Other key capabilities of the new line extension:

  • Updated data feed: In addition to end-user surveys of healthcare facilities, ChinaTrack data is paired with a database of procedure volumes for Tier 3 hospitals in China.
  • Online interactive dashboard: Full data and analysis is accessible in an interactive platform, with regular updates delivered shortly after the reporting period.
  • Key market coverage: Decision Resources Group offers coverage of the most active segments of the Chinese device markets, including:
    • Cardiac rhythm management and surgery
    • Electrophysiology
    • Ostomy
    • Vertebral compression fracture treatments
    • Heart valves

Comments from Decision Resources Group Director of Brand Solutions Jennifer Thomas:

  • "Across the China medical device industry, there is a strong unmet need for detailed market landscape information. ChinaTrack showcases the number of procedures by Tier 3 facility name to help our clients effectively strategize sales efforts in region. To provide such thorough procedure tracking at the hospital level for these Tier 3 facilities in China is completely novel."
  • "For a truly comprehensive view of the Chinese market, our expert analysts are now able to bring together usage data from end-user surveys and pair it with detailed facility-level procedures, published on an online interactive dashboard. We are thrilled to be the first provider of this type of competitive intelligence in China.

About Marketrack
Marketrack provides ongoing brand-level market share data from facilities in 40 countries and 20 medtech markets around the world, updated monthly or quarterly within 15 days following the reporting period. Each Marketrack ready-to-use deliverable provides a comprehensive and detailed view of a market of interest, including data on procedures, units used and average selling prices across a given device category.

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group 
Christopher Comfort 
781-993-2597  
ccomfort@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO


'/>"/>
SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement
2. Digital Resources Play Critical Role in Formulary Decision Making
3. Fattah Applauds Walgreens Decision to Cover Month of Medications for ACA Enrollees
4. Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Medical Mutual
5. Decision Resources to Publish Reports That Include Market Analysis and a Forecast through 2022 for the Hepatitis C Virus and Hospital-Treated Bacterial Infections Drug Markets
6. National Decision Support Company offers free access to ACR Select
7. Pharmspective Launches Affordable Care Act eLearning for Healthcare Decision-Makers
8. Pharmaceutical Industry Turning to Emerging Market Research Tools to Better Understand Consumer Decision-Making
9. Decision on State Exchanges Will Aid Patient Access to Medications
10. Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Humana, Inc.
11. Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):